enVVeno Medical Corporation (NVNO)
NASDAQ: NVNO · Real-Time Price · USD
8.98
+0.19 (2.10%)
At close: Sep 18, 2026, 4:00 PM EDT
9.15
+0.18 (1.95%)
After-hours: Sep 18, 2026, 4:20 PM EDT
enVVeno Medical Employees
enVVeno Medical had 33 employees as of December 31, 2025. The number of employees decreased by 4 or -10.81% compared to the previous year.
Employees
33
Change (1Y)
-4
Growth (1Y)
-10.81%
Revenue / Employee
n/a
Profits / Employee
-$476,485
Market Cap
6.13M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 33 | -4 | -10.81% |
| Dec 31, 2024 | 37 | 6 | 19.35% |
| Dec 31, 2023 | 31 | 1 | 3.33% |
| Dec 31, 2022 | 30 | 6 | 25.00% |
| Dec 31, 2021 | 24 | 5 | 26.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Trinity Biotech | 287 |
| WORK Medical Technology Group LTD | 238 |
| Co-Diagnostics | 115 |
| IceCure Medical | 69 |
| Intelligent Bio Solutions | 60 |
| VolitionRx | 57 |
| INVO Fertility | 42 |
| Autonomix Medical | 11 |
NVNO News
- 3 days ago - enVVeno Medical trading resumes - TheFly
- 3 days ago - enVVeno Medical trading halted, volatility trading pause - TheFly
- 8 days ago - enVVeno Medical Presentation from H.C. Wainwright Conference Now Available On-Demand - Accesswire
- 23 days ago - enVVeno Medical Participates in the Virtual Investor 'Why Now' On-Demand Conference - Accesswire
- 4 weeks ago - enVVeno Medical files $100M mixed securities shelf - TheFly
- 6 weeks ago - enVVeno announces publication of independent health economic study - TheFly
- 6 weeks ago - Independent Health Economic Study Recently Published in Journal of Vascular Surgery Reports Economic Dominance of enVVeno Medical's Replacement Venous Valve Therapy Compared to Standard of Care Treatments - Accesswire
- 7 weeks ago - enVVeno Medical reports Q2 EPS ($5.37) vs. ($11.52) last year - TheFly